Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

These medications for BPH have known risks and may have new side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Finasteride alone increases suicide risk, but combining it with other treatments reduces this risk.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Improving blood flow and oxygen levels in middle age may help prevent age-related diseases.

Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.

Low-dose finasteride may increase erectile dysfunction risk over time.

The FDA approved using Cialis with Proscar for better treatment options.

Persistent ED in Propecia users is not due to abnormal blood flow.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.